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1843p < 0.001; and group 4: 11.53  2.22 m/s vs.
13.17  1.54 m/s; p < 0.001) (Figure 1). In multivariate
regression analysis, PWV was independently related
to age group (b ¼ 0.61; p < 0.001), mean BP (b ¼ 0.29;
p ¼ 0.001), heart rate (b ¼ 0.23; p ¼ 0.006), and
creatinine (b ¼ 0.19; p ¼ 0.01); (R2 of the model: 0.59).
In the present study, we assessed aortic stiffness in
a population with high rates of longevity. Aortic stiff-
ness increases gradually with age; however, at >50
years of age, aortic stiffening seems to be decelerated
because the measured PWV was signiﬁcantly lower
than reference values. This ﬁnding may be attributed
to either a favorable hemodynamic pattern (progres-
sive increase in systolic BP with age, but stable dia-
stolic BP at older ages—an excessive decrease of
diastolic BP hampers coronary ﬂow) or to beneﬁcial
genetic and metabolic backgrounds that are impli-
cated in the process of both longevity and aortic
stiffness. The favorable lipid proﬁle and the relatively
low percentage of smokers among the elderly may
have contributed to the results (4). Moreover, previous
results from the IKARIA study showed a favorable ef-
fect of physical activity on endothelial function, which
may be related to attenuated aortic stiffening (1). He-
reditary aspects of aortic elasticity may also play a role
given the evidence that paternal longevity is associ-
ated with decreased PWV in offspring (5).
The cross-sectional nature of our study does not
allow for conclusions regarding causality, and selec-
tion bias may have interfered. Whether this privilege
of aortic mechanics can also be extended to the
younger generations living in the particular island is a
hypothesis that needs further investigation. Finally,
aortic imaging modalities that provide structural in-
formation could have enhanced our results.
Whether aortic stiffness retains its established pre-
dictive value with increasing age is an intriguing issue,
with most studies attesting to an incremental predic-
tive ability even at older ages. Given the adverse
prognostic impact of aortic stiffening on cardiovascu-
lar and total mortality, the present ﬁndings may imply
a possible link between longevity and aortic stiffness.*Panagiota Pietri, MD
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2702–7.Clinical Relevance of
Exaggerated Exercise
Blood PressureExercise stress testing is routinely used to assess
cardiovascular risk, and measurement of blood pres-
sure (BP) during the test is a standard component of
patient monitoring (1). Irrespective of whether BP is
considered normal at rest (in-clinic BP <140/90
mm Hg), some individuals may experience abnormal
(hypotensive or hypertensive) BP responses during
exercise testing. Our recent meta-analyses demon-
strated that abnormal BP responses carry signiﬁcant
risk for future cardiovascular events and mortality,
independent of resting BP and other cardiovascular
risk factors (2,3). Although exercise hypotension is a
sign of signiﬁcant cardiovascular pathology, it is
possible that some of the cardiovascular risk associ-
ated with exercise hypertension (exaggerated exer-
cise blood pressure [EEBP]) relates to underlying
(masked) hypertension (4) gone unnoticed with clinic
BP screening, or to future development of overt hy-
pertension detectable with in-clinic BP screening. A
pooled summary of studies assessing the relationship
between EEBP and incident hypertension has never
been undertaken, and is an important step with
respect to determining whether EEBP has utility
for early identiﬁcation of people at heightened car-
diovascular risk. Therefore, we sought to conduct a
systematic review and meta-analysis to determine
FIGURE 1 Pooled Risk Estimates
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Pooled risk estimates from 9 studies (adjusted for resting BP, age, sex, and
other cardiovascular risk factors) for the association between exaggerated
exercise blood pressure (EEBP) and incident hypertension. Risk estimates for
incident hypertension were pooled by EEBP deﬁned in 4 ways; A: at peak
exercise intensity on a categorical scale (orange); B: on a continuous scale
(green); C: at moderate exercise intensity on a categorical scale (blue); and D:
on a continuous scale (red). All pooled analyses show that EEBP (systolic BP)
was associated with signiﬁcantly increased risk for incident hypertension.
BP ¼ blood pressure; CI ¼ conﬁdence interval; RE ¼ risk estimate.
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sion among people with normal resting BP at baseline
examination.
We searched 7 online databases for studies mea-
suring dynamic exercise BP that reported incident
hypertension (deﬁned from clinic BP $140/90 mm Hg)
among those normotensive at baseline. Random-
effects meta-analysis was applied to pool risk esti-
mates (RE) for incident hypertension on the basis of
EEBP deﬁned from the systolic BP during exercise
(at moderate or peak intensity), or as the change in
systolic BP from rest. Data was analyzed comparing RE
on categorical (those with vs. those without EEBP) or
continuous (per 10 mm Hg increase) scales.
Quantitative RE were extracted for meta-analysis
from 16 studies that met the inclusion criteria, with
a total of 23,207 participants (mean age 42.4  7.1
years), followed for 5.3  2.1 years. Severalmeta-analyses were performed on the basis of
different deﬁnitions of EEBP. Pooling RE from 5
studies deﬁning EEBP at peak exercise intensity and 4
studies at moderate exercise intensity (adjusted for
resting BP, age, sex, and other cardiovascular risk
factors), revealed that EEBP (systolic BP) was associ-
ated with signiﬁcantly increased risk for incident
hypertension when compared with those without
EEBP (Figure 1). Similarly, each 10 mm Hg increase in
exercise systolic BP at peak (pooling 2 studies) and
moderate (pooling 2 studies) exercise intensity was
associated with increased risk of incident hyperten-
sion (Figure 1). When pooling 3 studies deﬁning EEBP
by change in systolic BP from rest to peak exercise
intensity, EEBP was associated with greater risk for
incident hypertension (RE: 1.98 [95% conﬁdence in-
terval (CI): 1.19 to 3.31], I2 ¼ 62.0%) compared to those
without EEBP. Further pooling of 9 studies that re-
ported RE unadjusted for resting BP or other cardio-
vascular risk factors (7 from EEBP deﬁned during
peak exercise, 2 from EEBP deﬁned at moderate)
revealed similar, positive associations between EEBP
and incident hypertension (RE: 1.97; [95% CI: 1.57 to
2.46], I2 ¼ 56.9% and RE: 2.26; [95% CI: 1.60 to 3.20],
I2 ¼ 16.7%, respectively).
This is the ﬁrst meta-analysis to demonstrate that
EEBP predicts incident hypertension independently
of in-clinic resting BP and other cardiovascular risk
factors. This analysis provides evidence to support
the clinical value of EEBP to detect cardiovascular
risk related to BP that would remain otherwise un-
detectable by conventional (resting) BP measure-
ments. Millions of clinical exercise stress tests are
conducted worldwide every year, with BP as a
standard measurement. Our ﬁndings suggest that
EEBP should alert supervising physicians to a
heightened level of cardiovascular risk associated
with BP, and this should warrant further investiga-
tion with respect to BP control and/or lifestyle
intervention.Martin G. Schultz, PhD
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True Prevalence of
Hypertrophic Cardiomyopathy?
ceding text, only 6 of these
dently classiﬁed as likely p
(i.e., 6 of 3,600, or approxi
carrier frequency). In viewIn a recent paper by Semsarian et al. (1), several
arguments are presented indicating that the preva-
lence of clinically expressed and hypertrophic car-
diomyopathy (HCM) gene carriers has been greatly
underestimated and could be as high as 1:200. This
updated frequency estimate was primarily on the
basis of a genetic analysis, published in 2012, that
demonstrated 22 of 3,600 participants from the Fra-
mingham Heart Study and Jackson Heart Study co-
horts had likely pathogenic or pathogenic sarcomeric
gene variants (2). Although Semsarian et al. (1) stated
that the variants were classiﬁed “using stringent
criteria for pathogenicity,” it is important to note that
since 2012, there have been signiﬁcant advancements
in the tools to aid in variant classiﬁcation (i.e.,
determining whether a variant is benign or
pathogenic).
Technological advances have allowed us to more
comprehensively and efﬁciently interrogate human
genomes, and there are a number of large-scale
efforts, such as the Exome Sequencing Project and
Exome Aggregation Consortium, which have been
publishing genomic data and variant frequencies
from very large populations stratiﬁed by ethnicity.
These large-scale efforts are important for variant
classiﬁcation because they provide population minor
allele frequencies that, when used in concert with
disease prevalence estimates, may push a variant
into a benign or pathogenic category. Furthermore,
databases such as ClinVar (3) and Human Genome
Mutation Database make it easier for us to access
variant classiﬁcations and publications by different
clinical laboratories and groups. Variant data, fromeven just a few short years ago, should be reviewed
through the lens of these new resources, and revisited
accordingly, in this rapidly changing landscape.
As such, we took a closer look at the 22 variants
classiﬁed as pathogenic or likely pathogenic by
Bick et al. (2). The vast majority (20 of 22) of these
variants were missense variants, which tend to be less
straightforward to classify. Interestingly, only 4 of
the 22 individuals actually expressed HCM (but were
not speciﬁed by Bick et al. [2]). Utilizing our criteria
for variant classiﬁcation, which is largely on the basis
of the American College of Medical Genetics and Ge-
nomics and the Association for Molecular Pathology
2015 guidelines for variant interpretation (4) and
utilizes databases and resources listed in the pre-
variants could be conﬁ-
athogenic or pathogenic
mately 1:600 HCM gene
ing ClinVar data, we
observed that the Harvard Laboratory for Molecular
Medicine (whom participated in the original Bick
et al. [2] variant classiﬁcation) currently classiﬁes 12
of the 22 variants as variants of uncertain signiﬁcance
(equating to an HCM gene carrier frequency of 1:360).
Assessment of these 22 variants illustrates the
somewhat subjective and rapidly evolving nature of
genetic variant classiﬁcation. After applying con-
temporary variant classiﬁcation strategies to the 2012
data, the resultant data would not support a frequency
as high as 1:200. Rather, it would seem to continue to
support the 1:500 frequency of the disease more
prevalently referenced in the published data. This
frequency would take into account reduced pene-
trance (i.e., gene-positive, phenotype-negative cases),
as well as HCM caseswith nongenetic causes.With that
said, these numbers will likely continue to change
as our variant interpretation strategies continue
to evolve. More standardized variant classiﬁcation
criteria would be helpful and improvements in that
area have been made (3,4). However, the complexities
of variant classiﬁcation will likely continue to leave
this ﬁeld somewhat in ﬂux, and the example with HCM
presented here is likely just the tip of the iceberg.*Linnea M. Baudhuin, PhD
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